Federal court finds two Latisse patents invalid

Washington, D.C.—The U.S. Court of Appeals for the Federal Circuit in Washington, D.C. recently found a pair of patents for Allergan’s Latisse (bimatoprost) invalid and threw out an order preventing Novartis’ Sandoz unit, Actavis and generic drug company Apotex Inc. » More

Support Pediatric Vision Services under the Affordable Care Act with Spot
Spot is the award-winning, handheld, binocular autorefractor that can help identify refractive errors easily on patients as young as six months with results in seconds. Adding children to your patient base just got a little easier. Learn More.

Essilor introduces new generation of Optifog lenses

Dallas—In July, Essilor plans to launch a new generation of Optifog lenses that the company says will make the lenses easier to use because the patient will no longer need to apply a special liquid weekly to activate the anti-fog property. » More

Alden Optical launches Zenlens

Alden, NY—Alden Optical recently launched Zenlens, its new mini-scleral design co-designed with Jason Jedlicka, OD, FAAO, FSLS, president of the Scleral Lens Education Society. » More

Study: coefficient of friction of 1-Day Acuvue TruEye, Acuvue Oasys comparable to human cornea

Birmingham, UK—According to research presented at the 2014 British Contact Lens Association Clinical Conference found the coefficient of friction of the 1-Day Acuvue TruEeye and Acuvue Oasys brand contact lenses were comparable to that of the human cornea. » More

CONNECT WITH Optometry Times

Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today!

» Facebook

» Twitter